Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис: http://hdl.handle.net/20.500.12188/12942
DC FieldValueLanguage
dc.contributor.authorHalimi Vesaen_US
dc.contributor.authorDaci Armonden_US
dc.contributor.authorSimona Stojanovskaen_US
dc.contributor.authorPanovska-Stavridis Irinaen_US
dc.contributor.authorMilena Stevanovicen_US
dc.contributor.authorFilipce Venkoen_US
dc.contributor.authorGrozdanova, Aleksandraen_US
dc.date.accessioned2021-05-31T12:21:23Z-
dc.date.available2021-05-31T12:21:23Z-
dc.date.issued2020-05-16-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/12942-
dc.language.isoenen_US
dc.publisherJournal of Pharmaceutical Policy and Practiceen_US
dc.titleCurrent regulatory approaches for accessing potential COVID-19 therapiesen_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.1186/s40545-020-00222-6-
item.grantfulltextopen-
item.fulltextWith Fulltext-
crisitem.author.deptFaculty of Pharmacy-
Appears in Collections:Faculty of Pharmacy: Journal Articles
Files in This Item:
File Опис SizeFormat 
s40545-020-00222-6.pdf488.99 kBAdobe PDFView/Open
Прикажи едноставен запис

Page view(s)

85
checked on 23.6.2025

Download(s)

19
checked on 23.6.2025

Google ScholarTM

Проверете

Altmetric


Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.